Cetuximab PET delineated changes in cellular distribution of EGFR upon dasatinib treatment in triple negative breast cancer

por McKnight, Brooke N., Kim, Seongho, Boerner, Julie L., Viola, Nerissa T.
Publicado 2020

EGFR/Met association regulates EGFR TKI resistance in breast cancer

por Mueller, Kelly L, Yang, Zeng-Quan, Haddad, Ramsi, Ethier, Stephen P, Boerner, Julie L
Publicado 2010

Fibroblast-secreted hepatocyte growth factor mediates epidermal growth factor receptor tyrosine kinase inhibitor resistance in triple-negative breast cancers through paracrine acti...

por Mueller, Kelly L, Madden, Julie M, Zoratti, Gina L, Kuperwasser, Charlotte, List, Karin, Boerner, Julie L
Publicado 2012

CLCA2 expression is associated with survival among African American women with triple negative breast cancer

por Purrington, Kristen S., Knight, Jimmie, Dyson, Gregory, Ali-Fehmi, Rouba, Schwartz, Ann G., Boerner, Julie L., Bandyopadhyay, Sudeshna
Publicado 2020

Downregulation of Rap1Gap: A Switch from DCIS to Invasive Breast Carcinoma via ERK/MAPK Activation()

por Shah, Seema, Brock, Ethan J., Jackson, Ryan M., Ji, Kyungmin, Boerner, Julie L., Sloane, Bonnie F., Mattingly, Raymond R.
Publicado 2018

Sprouty4 negatively regulates ERK/MAPK signaling and the transition from in situ to invasive breast ductal carcinoma

por Brock, Ethan J., Jackson, Ryan M., Boerner, Julie L., Li, Quanwen, Tennis, Meredith A., Sloane, Bonnie F., Mattingly, Raymond R.
Publicado 2021

Protein Expression of DNA Damage Repair Proteins Dictates Response to Topoisomerase and PARP Inhibitors in Triple-Negative Breast Cancer

por Boerner, Julie L., Nechiporchik, Nicole, Mueller, Kelly L., Polin, Lisa, Heilbrun, Lance, Boerner, Scott A., Zoratti, Gina L., Stark, Karri, LoRusso, Patricia M., Burger, Angelika
Publicado 2015

Treating triple negative breast cancer cells with erlotinib plus a select antioxidant overcomes drug resistance by targeting cancer cell heterogeneity

por Bao, Bin, Mitrea, Cristina, Wijesinghe, Priyanga, Marchetti, Luca, Girsch, Emily, Farr, Rebecca L., Boerner, Julie L, Mohammad, Ramzi, Dyson, Greg, Terlecky, Stanley R., Bollig-Fischer, Aliccia
Publicado 2017

Targeting MET and EGFR crosstalk signaling in triple-negative breast cancers

por Linklater, Erik S., Tovar, Elizabeth A., Essenburg, Curt J., Turner, Lisa, Madaj, Zachary, Winn, Mary E., Melnik, Marianne K., Korkaya, Hasan, Maroun, Christiane R., Christensen, James G., Steensma, Matthew R., Boerner, Julie L., Graveel, Carrie R.
Publicado 2016